S
Stockadora
Back to Insider Trading View Full Company Profile

APGE

UNKNOWN

Apogee Therapeutics, Inc.

CIK: 0001974640

Strong Sell (90% confidence)

Last activity: 6 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $118.32M

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Fairmount Funds Management LLC
DIRECTOR
 		0 1 -$133.53M
298,647 shares
$22.79M
HENDERSON MICHAEL THOMAS
Chief Executive Officer
 		0 16 -$8.89M
1,164,624 shares
$86.52M
Dambkowski Carl
Chief Medical Officer
 		0 13 -$3.03M
212,048 shares
$14.91M
Henderson Jane
Chief Financial Officer
 		0 13 -$1.28M
179,371 shares
$15.25M

Recent Transactions

SELL Henderson Jane (Chief Financial Officer)

2,000 shares @ $85.00

$170K

Mar 25, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

8,363 shares @ $74.29

$621K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

8,219 shares @ $74.83

$615K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

3,418 shares @ $75.86

$259K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

3,225 shares @ $70.33

$227K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

2,075 shares @ $71.98

$149K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

200 shares @ $73.26

$15K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

994 shares @ $70.45

$70K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

406 shares @ $71.66

$29K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

300 shares @ $69.43

$21K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

300 shares @ $68.27

$20K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

11,494 shares @ $62.96

$724K

Feb 11, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

7,551 shares @ $63.73

$481K

Feb 11, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

955 shares @ $64.99

$62K

Feb 11, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

2,481 shares @ $64.88

$161K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

1,420 shares @ $65.83

$93K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

1,299 shares @ $66.85

$87K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

200 shares @ $68.94

$14K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

100 shares @ $67.88

$7K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

1,108 shares @ $66.15

$73K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

792 shares @ $65.21

$52K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

100 shares @ $66.89

$7K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Fairmount Funds Management LLC (DIRECTOR)

1,750,000 shares @ $76.30

$133.53M

Jan 22, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

8,476 shares @ $79.82

$677K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

5,386 shares @ $83.16

$448K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

2,374 shares @ $81.00

$192K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

1,854 shares @ $82.41

$153K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

1,440 shares @ $78.64

$113K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

470 shares @ $83.79

$39K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

14,820 shares @ $77.90

$1.15M

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

2,954 shares @ $77.13

$228K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

826 shares @ $79.04

$65K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

100 shares @ $80.06

$8K

Jan 7, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

2,000 shares @ $80.00

$160K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

4,080 shares @ $75.20

$307K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

1,920 shares @ $74.13

$142K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

1,500 shares @ $80.00

$120K

Dec 19, 2025

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

10,005 shares @ $75.79

$758K

Dec 10, 2025

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

9,435 shares @ $74.88

$706K

Dec 10, 2025

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

560 shares @ $76.58

$43K

Dec 10, 2025

Conviction: | View SEC Filing →
SELL HENDERSON MICHAEL THOMAS (Chief Executive Officer)

40,000 shares @ $75.01

$3.00M

Dec 4, 2025

Conviction: | View SEC Filing →
SELL Dambkowski Carl (Chief Medical Officer)

10,900 shares @ $75.00

$818K

Dec 4, 2025

Conviction: | View SEC Filing →
SELL Henderson Jane (Chief Financial Officer)

1,500 shares @ $75.00

$113K

Dec 4, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.